HK
ABBV icon

Horizon Kinetics’s AbbVie ABBV Stock Holding History

Horizon Kinetics’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2.73M Buy
29,609
+266
+0.9% +$23.4K 0.09% 90
2018
Q3 		$2.77M Sell
29,343
-2,981
-9% -$283K 0.07% 95
2018
Q2 		$2.99M Buy
32,324
+56
+0.2% +$5.47K 0.08% 86
2018
Q1 		$3.05M Sell
32,268
-781
-2% -$85.8K 0.09% 83
2017
Q4 		$3.2M Sell
33,049
-150
-0.5% -$14.1K 0.09% 87
2017
Q3 		$2.95M Sell
33,199
-152
-0.5% -$11.6K 0.09% 92
2017
Q2 		$2.42M Sell
33,351
-102
-0.3% -$6.86K 0.08% 104
2017
Q1 		$2.18M Sell
33,453
-401
-1% -$25.2K 0.07% 115
2016
Q4 		$2.12M Sell
33,854
-1,202
-3% -$73.4K 0.07% 113
2016
Q3 		$2.21M Buy
35,056
+301
+0.9% +$19.5K 0.06% 122
2016
Q2 		$2.15M Sell
34,755
-1,399
-4% -$85.2K 0.05% 125
2016
Q1 		$2.06M Buy
36,154
+135
+0.4% +$7.52K 0.05% 122
2015
Q4 		$2.13M Buy
36,019
+898
+3% +$51.7K 0.05% 129
2015
Q3 		$1.91M Buy
35,121
+3,061
+10% +$199K 0.03% 137
2015
Q2 		$2.15M Sell
32,060
-4
-0% -$261 0.03% 149
2015
Q1 		$1.88M Sell
32,064
-3,094
-9% -$187K 0.03% 166
2014
Q4 		$2.3M Sell
35,158
-107
-0.3% -$6.75K 0.03% 161
2014
Q3 		$2.04M Sell
35,265
-8
-0% -$444 0.03% 160
2014
Q2 		$1.99M Sell
35,273
-609
-2% -$31.9K 0.02% 162
2014
Q1 		$1.84M Buy
35,882
+597
+2% +$30.2K 0.02% 171
2013
Q4 		$1.86M Buy
35,285
+1,445
+4% +$71K 0.02% 172
2013
Q3 		$1.51M Buy
33,840
+153
+0.5% +$6.78K 0.02% 185
2013
Q2 		$1.39M Buy
+33,687
New +$1.47M 0.02% 197

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Horizon Kinetics's ABBV Position: Q4 2018 in Review

Horizon Kinetics increased its AbbVie (ABBV) stake by 0.91% in Q4 2018, buying an estimated $23.4K and bringing the position to 29,609 shares worth $2.73M. The position accounts for 0.09% of the portfolio, ranked #90.

Horizon Kinetics first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. The position peaked at $3.2M in Q4 2017. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Horizon Kinetics held 29,609 shares of AbbVie worth $2.73M as of Q4 2018.
  • Horizon Kinetics bought 266 AbbVie shares in Q4 2018, an estimated $23.4K.
  • AbbVie made up 0.09% of Horizon Kinetics's portfolio in Q4 2018, its #90 holding.
  • Horizon Kinetics first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
  • Horizon Kinetics's AbbVie position peaked at $3.2M in Q4 2017.
  • 2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.